↓ Skip to main content

Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease

Overview of attention for article published in BMC Pulmonary Medicine, December 2013
Altmetric Badge

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Plasma YKL-40 and all-cause mortality in patients with chronic obstructive pulmonary disease
Published in
BMC Pulmonary Medicine, December 2013
DOI 10.1186/1471-2466-13-77
Pubmed ID
Authors

Dennis B Holmgaard, Lone H Mygind, Ingrid L Titlestad, Hanne Madsen, Svend Stenvang Pedersen, Julia S Johansen, Court Pedersen

Abstract

Chronic obstructive pulmonary disease (COPD) is hallmarked by inflammatory processes and a progressive decline of lung function. YKL-40 is a potential biomarker of inflammation and mortality in patients suffering from inflammatory lung disease, but its prognostic value in patients with COPD remains unknown. We investigated whether high plasma YKL-40 was associated with increased mortality in patients with moderate to very severe COPD.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 40 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 18%
Student > Bachelor 6 15%
Student > Ph. D. Student 4 10%
Student > Doctoral Student 3 8%
Other 3 8%
Other 10 25%
Unknown 7 18%
Readers by discipline Count As %
Medicine and Dentistry 16 40%
Biochemistry, Genetics and Molecular Biology 5 13%
Agricultural and Biological Sciences 3 8%
Nursing and Health Professions 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Other 3 8%
Unknown 9 23%